Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
UCB Japan announced on April 18 that Kanako Kikuchi, former president of the Japan arm of GlaxoSmithKline PLC, would be appointed to lead the company from May 1. Graduated from the faculty of pharmaceutical sciences at Hokkaido University, Ms Kikuchi…
To read the full story
Related Article
- GSK Japan Pres. Kikuchi to Quit after Only 9 Months in Office
December 20, 2017
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





